GlucoTrack, Inc.(GCTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GCTK GlucoTrack, Inc.

Post-Market Trading 12-27 16:56:29 EST

0.2620

-0.0020

-0.76%

盘后0.2618

-0.0002-0.08%

16:52 EST

High0.2625	Low0.2515	Vol161.34K
Open0.2600	D1 Closing0.2640	Amplitude4.17%
Mkt Cap4.21M	Tradable Cap2.94M	Total Shares16.05M
T/O41.76K	T/O Rate1.44%	Tradable Shares11.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GCTK","market":"US","secType":"STK","nameCN":"GlucoTrack, Inc.","latestPrice":0.262,"timestamp":1735333200000,"preClose":0.264,"halted":0,"volume":161344,"hourTrading":{"tag":"盘后","latestPrice":0.2618,"preClose":0.262,"latestTime":"16:52 EST","volume":205,"amount":53.708001249999995,"timestamp":1735336327001},"delay":0,"floatShares":11204000,"shares":16052200,"eps":-2.888258,"marketStatus":"Post-Market Trading","change":-0.002,"latestTime":"12-27 16:56:29 EST","open":0.26,"high":0.2625,"low":0.2515,"amount":41762.174472959996,"amplitude":0.041667,"askPrice":0.2621,"askSize":2000,"bidPrice":0.2521,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-2.888258,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1735347600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.264,"preHourTrading":{"tag":"盘前","latestPrice":0.2697,"preClose":0.264,"latestTime":"08:57 EST","volume":2694,"amount":717.8836500000001,"timestamp":1735307859692},"postHourTrading":{"tag":"盘后","latestPrice":0.2618,"preClose":0.262,"latestTime":"16:52 EST","volume":205,"amount":53.708001249999995,"timestamp":1735336327001},"volumeRatio":0.44531},"requestUrl":"/m/hq/s/GCTK/tweets","defaultTab":"tweets","newsList":[{"id":"2492919790","title":"BRIEF-Glucotrack Inc - Enters ATM Sales Agreement With Dawson James","url":"https://stock-news.laohu8.com/highlight/detail?id=2492919790","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492919790?lang=en_us&edition=fundamental","pubTime":"2024-12-18 06:30","pubTimestamp":1734474626,"startTime":"0","endTime":"0","summary":"BRIEF-Glucotrack Inc - Enters ATM Sales Agreement With Dawson JamesDec 17  - GlucoTrack Inc GCTK.O:GLUCOTRACK INC - ENTERS ATM SALES AGREEMENT WITH DAWSON JAMESGLUCOTRACK INC - AGGREGATE OFFERING PRICE UP TO $8.23 MILLIONSource text: [ID:n0001493152-24-050462]Further company coverage: GCTK.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI18G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK"],"gpt_icon":0},{"id":"2492919499","title":"GlucoTrack Inc - Enters Atm Sales Agreement With Dawson James","url":"https://stock-news.laohu8.com/highlight/detail?id=2492919499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492919499?lang=en_us&edition=fundamental","pubTime":"2024-12-18 06:28","pubTimestamp":1734474528,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI18G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2492192739","title":"GlucoTrack Inc - Aggregate Offering Price up to $8.23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2492192739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492192739?lang=en_us&edition=fundamental","pubTime":"2024-12-18 06:28","pubTimestamp":1734474528,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI18G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GCTK","BK4082"],"gpt_icon":0},{"id":"2488542948","title":"GlucoTrack announces start of enrollment for human clinical study of CBGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2488542948","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488542948?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:45","pubTimestamp":1733233555,"startTime":"0","endTime":"0","summary":"Glucotrack (GCTK) has announced the commencement of patient enrollment for its short-term human clinical study. The study will focus on the Company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/glucotrack-announces-start-of-enrollment-for-human-clinical-study-of-cbgm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/glucotrack-announces-start-of-enrollment-for-human-clinical-study-of-cbgm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2488917552","title":"GlucoTrack Announces Start of Enrollment for Human Clinical Study of Continuous Blood Glucose Monitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917552?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA9XCFWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GCTK","BK4082"],"gpt_icon":0},{"id":"2488917200","title":"GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917200","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917200?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":"Feasibility study underway for the Company’s novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks Rutherford, NJ, Dec.  03, 2024  (GLOBE NEWSWIRE) -- G","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990630/0/en/GLUCOTRACK-ANNOUNCES-START-OF-ENROLLMENT-FOR-HUMAN-CLINICAL-STUDY-OF-CONTINUOUS-BLOOD-GLUCOSE-MONITOR.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOR","WRD","BK4082","GCTK","BK4024"],"gpt_icon":0},{"id":"2483340358","title":"GlucoTrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2483340358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483340358?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA4XDRLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2483589493","title":"Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2483589493","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483589493?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619800,"startTime":"0","endTime":"0","summary":"Rutherford, NJ., Nov.  14, 2024  (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981658/0/en/Glucotrack-Inc-Announces-Closing-of-10-0-Million-Public-Offering-and-Concurrent-Private-Placement-Converting-4-0-in-Outstanding-Debt.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"gpt_icon":1},{"id":"2483529859","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2483529859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483529859?lang=en_us&edition=fundamental","pubTime":"2024-11-14 03:25","pubTimestamp":1731525910,"startTime":"0","endTime":"0","summary":"Glucotrack  unveiled on Wednesday a public offering of about 7.2 million shares of its common stock.Shares of the medical technology company slumped past 77%, with intraday trading volume at over 5.2 million compared with a daily average of about 80,000.Media outlets reported late Tuesday that Spirit Airlines  may seek bankruptcy protection after its merger discussions with Frontier  fell apart.Spirit's shares plunged 58% as intraday trading volume rose to more than 65.2 million, versus their daily average of about 10.4 million.Gaucho Group  said Wednesday it filed for Chapter 11 reorganization to protect its assets, including Algodon Mansion and Algodon Wine Estates in Argentina, and to ensure continued operations.Shares retreated 48% as intraday trading volume climbed to more than 220,000, compared with its daily average of roughly 16,000.Price: 0.35, Change: -1.21, Percent Change: -77.31","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SAVE.AU","BK4500","GCTK","BK4206","BK4539","SAVE","VINO","BK4082","BK4008","ULCC"],"gpt_icon":0},{"id":"2483358338","title":"BUZZ-U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358338","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358338?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:01","pubTimestamp":1731513678,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-BankUnited, Natera, AdaptimmuneEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4N3MK1NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAVA","MVST","GEV","MPWR","GDYN","ADAP","HTLD","COTY","PET","BKU","SYRS","LU1914381329.SGD","DAVE","HON","BW","PLTR","POAI","LU2756315318.SGD","NTRA","VVX","SSYS","SAVE","SAIA","SG9999015986.USD","BRTX","LU2098885051.SGD","CTRA","BK4211","AMPS","LU0964806797.USD","ALUR","RIVN","KNX","KLAC","CART","GCTK","TSLA","AMGN","ALB","BARC.UK","MARA","PAY","SWKS","SPOT","ODFL","ETNB","LXEO","CAT","LU0683600562.USD"],"gpt_icon":1},{"id":"2483882500","title":"US Stocks Mixed; Inflation Rate Increases In October","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882500","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483882500?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:02","pubTimestamp":1731510120,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/24/11/41942279/us-stocks-mixed-inflation-rate-increases-in-october","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4023","TQQQ","SQQQ","BK4149","BK4214","MNQmain","KXIN","MVST",".IXIC","SYRS","NQmain","QID","BK4139","BK4204","PSQ","BK4082","GCTK","BTCT","BK4547","QLD","PET"],"gpt_icon":1},{"id":"2483886482","title":"GlucoTrack prices 7.2M shares at $1.39 in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483886482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483886482?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:11","pubTimestamp":1731507115,"startTime":"0","endTime":"0","summary":"Glucotrack (GCTK) announced the launch of a “best efforts” public offering of approximately 7,195,000 shares of common stock with each share of com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/glucotrack-prices-7-2m-shares-at-1-39-in-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/glucotrack-prices-7-2m-shares-at-1-39-in-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2483885478","title":"BRIEF-Glucotrack, Inc. Announces Pricing Of $10.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483885478","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483885478?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:07","pubTimestamp":1731506879,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - GlucoTrack Inc   :   * GLUCOTRACK, INC. ANNOUNCES PRICING OF $10.0 MILLION PUBLIC OFFERING   * GLUCOTRACK INC - LAUNCHES PUBLIC OFFERING OF APPROXIMATELY 7.2 MILLION SHARESSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","BK4082"],"gpt_icon":0},{"id":"2483853228","title":"GlucoTrack, Inc. Announces Pricing of $10.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483853228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483853228?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:00","pubTimestamp":1731506405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA8Q064K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GCTK","BK4082"],"gpt_icon":0},{"id":"2483851118","title":"GlucoTrack Inc - Launches Public Offering of Approximately 7.2 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851118","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483851118?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:00","pubTimestamp":1731506405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA8Q064K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2483859058","title":"Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483859058","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483859058?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:00","pubTimestamp":1731506400,"startTime":"0","endTime":"0","summary":"Rutherford, NJ., Nov.  13, 2024  (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/13/2980350/0/en/Glucotrack-Inc-Announces-Pricing-of-10-0-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"gpt_icon":1},{"id":"2477190331","title":"GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE","url":"https://stock-news.laohu8.com/highlight/detail?id=2477190331","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477190331?lang=en_us&edition=fundamental","pubTime":"2024-10-22 21:00","pubTimestamp":1729602000,"startTime":"0","endTime":"0","summary":"Continuous blood glucose monitor to be among 100+ future-focused presentations at industry investor conference. Rutherford, NJ, Oct. 22, 2024  -- Glucotrack, Inc.  , a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the 2024 BioFuture Conference, to be held at Cure in New York City from October 28-30, 2024.This year’s BioFuture program explores topics including next-generation applications of quantum computing and biology, alternative financing, how artificial intelligence  will impact healthcare, the use of psychedelics in mental health treatments, bioethical challenges, and more. Speakers from Regeneron Pharmaceuticals, Ipsen, IBM, Rock Health, Ray Therapeutics, Mineralys Therapeutics, Andreessen Horowitz , and JP Morgan, among many others, will bring insights into the major trends shaping the future of healthcare.For more information about Glucotrack’s CBG","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/driXWLBopDBIUzYV0Liy1A--~B/aD02Nzt3PTMxNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/f35d29fdcba1dce85531dd5c02f9fd07","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/driXWLBopDBIUzYV0Liy1A--~B/aD02Nzt3PTMxNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/f35d29fdcba1dce85531dd5c02f9fd07"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/glucotrack-present-2024-biofuture-conference-130000439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","WRD","GCTK"],"gpt_icon":0},{"id":"2472320490","title":"GlucoTrack Announces Oral & Poster Presentations at the 2024 Diabetes Technology Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2472320490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472320490?lang=en_us&edition=fundamental","pubTime":"2024-10-01 21:00","pubTimestamp":1727787607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nTUA5HKHNP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2472378399","title":"GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING","url":"https://stock-news.laohu8.com/highlight/detail?id=2472378399","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472378399?lang=en_us&edition=fundamental","pubTime":"2024-10-01 21:00","pubTimestamp":1727787600,"startTime":"0","endTime":"0","summary":"Updated preclinical data for the continuous blood glucose monitor to be presented at major diabetes technology conference  Rutherford, NJ, Oct.  01, 2024  (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/01/2956181/0/en/GLUCOTRACK-ANNOUNCES-ORAL-POSTER-PRESENTATIONS-AT-THE-2024-DIABETES-TECHNOLOGY-MEETING.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GCTK"],"gpt_icon":0},{"id":"2469717277","title":"GlucoTrack files for $30M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2469717277","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469717277?lang=en_us&edition=fundamental","pubTime":"2024-09-24 05:43","pubTimestamp":1727127825,"startTime":"0","endTime":"0","summary":"GlucoTrack (NASDAQ:GCTK) filed for $30M mixed securities shelf.\nThis prospectus is not an offer to sell.\nFiling","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4152348-glucotrack-files-for-30m-mixed-securities-shelf","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4082","GCTK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.integrity-app.com","stockEarnings":[{"period":"1week","weight":0.1908},{"period":"1month","weight":0.0535},{"period":"3month","weight":-0.8918},{"period":"6month","weight":-0.8687},{"period":"1year","weight":-0.8122},{"period":"ytd","weight":-0.7981}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0523},{"period":"6month","weight":0.105},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.2652}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.155577},{"month":2,"riseRate":0.5,"avgChangeRate":0.064425},{"month":3,"riseRate":0.5,"avgChangeRate":-0.18882},{"month":4,"riseRate":0.666667,"avgChangeRate":0.152109},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.043836},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.0329},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.050528},{"month":8,"riseRate":0.285714,"avgChangeRate":0.046963},{"month":9,"riseRate":0.571429,"avgChangeRate":0.094509},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.183831},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.148803},{"month":12,"riseRate":0.571429,"avgChangeRate":0.288904}],"exchange":"NASDAQ","name":"GlucoTrack, Inc.","nameEN":"GlucoTrack, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlucoTrack, Inc.(GCTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlucoTrack, Inc.(GCTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlucoTrack, Inc.,GCTK,GlucoTrack, Inc.股票,GlucoTrack, Inc.股票老虎,GlucoTrack, Inc.股票老虎国际,GlucoTrack, Inc.行情,GlucoTrack, Inc.股票行情,GlucoTrack, Inc.股价,GlucoTrack, Inc.股市,GlucoTrack, Inc.股票价格,GlucoTrack, Inc.股票交易,GlucoTrack, Inc.股票购买,GlucoTrack, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlucoTrack, Inc.(GCTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlucoTrack, Inc.(GCTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction